Sho Isogai

628 total citations
24 papers, 551 citations indexed

About

Sho Isogai is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Sho Isogai has authored 24 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Sho Isogai's work include Chronic Kidney Disease and Diabetes (5 papers), Advanced Glycation End Products research (5 papers) and Protease and Inhibitor Mechanisms (3 papers). Sho Isogai is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Advanced Glycation End Products research (5 papers) and Protease and Inhibitor Mechanisms (3 papers). Sho Isogai collaborates with scholars based in Japan and China. Sho Isogai's co-authors include Makoto Hoshino, Yutaka Nakamura, Hayato Tada, Gen Yoshino, Yasuo Oshima, Kenji Ohe, Koji Kuboki, Toshiko Takao, Tsutomu Urayama and Y. Totsuka and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Diabetologia and Metabolism.

In The Last Decade

Sho Isogai

23 papers receiving 539 citations

Peers

Countries citing papers authored by Sho Isogai

Since Specialization

Citations

This map shows the geographic impact of Sho Isogai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Isogai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Isogai more than expected).

Fields of papers citing papers by Sho Isogai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Isogai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Isogai. The network helps show where Sho Isogai may publish in the future.

Co-authorship network of co-authors of Sho Isogai

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Isogai. A scholar is included among the top collaborators of Sho Isogai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Isogai. Sho Isogai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An impairment of barrier size and charge selectivity of glomerular basement membrane in streptozotocin-induced diabetes and prevention by pharmacological therapy 2000 ·PubMed ·Sho Isogai, (unknown), (unknown), Gen Yoshino	6
2	Initial Ultrastructural Changes in Pore Size and Anionic Sites of the Glomerular Basement Membrane in Streptozotocin-Induced Diabetic Rats and Their Prevention by Insulin Treatment 1999 ·The Nephron journals/Nephron journals ·Sho Isogai, (unknown), (unknown), Gen Yoshino	19
3	Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation 1998 ·Journal of Allergy and Clinical Immunology ·Makoto Hoshino, Yutaka Nakamura, (unknown), (unknown), Sho Isogai	249
4	The Fibronectin Production Is Increased by Thrombospondin via Activation of TGF-β in Cultured Human Mesangial Cells 1998 ·The Nephron journals/Nephron journals ·(unknown), Sho Isogai	33
5	Protective Effects of a Small Dose of Captopril on the Reduction of Glomerular Basement Membrane Anionic Sites in Spontaneously Hypertensive Rats with Streptozotocin-Induced Diabetes 1998 ·Journal of Diabetes and its Complications ·Sho Isogai, (unknown), (unknown), Gen Yoshino	15
6	An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-? and protein kinase C activity in cultured human mesangial cells 1998 ·Diabetologia ·(unknown), Hayato Tada, Sho Isogai	62
7	Protective effect of d-α-tocopherol on the function of human mesangial cells exposed to high glucose concentrations 1997 ·Metabolism ·(unknown), (unknown), Sho Isogai	33
8	Changes in carnitine metabolism with ketone body production in obese glucose-intolerant patients 1995 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), (unknown), Sho Isogai	13
9	Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats 1995 ·Diabetes Research and Clinical Practice ·Sho Isogai, (unknown), Kenji Ohe	10
10	Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study. 1995 ·PubMed ·Hiroshi Koide, Y. Totsuka, Tetsuzo Sugisaki, T Kitajima, (unknown), (unknown), (unknown), Sho Isogai, Hiroyuki Ohi, (unknown)	7
11	A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells 1994 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), Sho Isogai	16
12	Protective effect of heparin on renal glomerular anionic sites of streptozotocin-injected rats 1994 ·Diabetes Research and Clinical Practice ·Yasuo Oshima, Sho Isogai, (unknown), (unknown), Kenji Ohe	20
13	Relationship between urinary excretion of fibronectin degradation products and proteinuria in diabetic patients, and their suppression after continuous subcutaneous heparin infusion 1993 ·Diabetes Research and Clinical Practice ·Koji Kuboki, (unknown), Koki Shin, Yasuo Oshima, Sho Isogai	7
14	Resistance to Ketosis in Moderately Obese Patients: Influence of Fatty Liver. 1992 ·Internal Medicine ·(unknown), (unknown), (unknown), Toshiko Takao, Sho Isogai	16
15	Increased intraglomerular thrombin formation in diabetic microangiopathy 1989 ·Diabetes Research and Clinical Practice ·(unknown), Koji Kuboki, Yasuo Oshima, (unknown), Sho Isogai	6
16	Elevated pancreatic glucagon in moderately obese patients. Relationship of fatty liver and hypertriglyceridemia. 1989 ·Japanese Journal of Medicine ·(unknown), (unknown), (unknown), (unknown), Sho Isogai	3
17	Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics 1987 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), Sho Isogai	10
18	Clinical significance of urinary fibronectin degradation products excretion in the development of diabetic nephropathy 1987 ·Diabetes Research and Clinical Practice ·Sho Isogai, (unknown), Koji Kuboki, Shotaro Takeuchi, Miyuki Takagi, Yasuo Oshima, (unknown)	7
19	The effect of glycemic control on plasma soluble fibrin monomer complexes and fibronectin in diabetic patients. 1987 ·The Tohoku Journal of Experimental Medicine ·(unknown), (unknown), Masato Takagi, Sho Isogai	3
20	Plasma soluble fibrin monomer complexes in diabetic microangiopathy. 1982 ·Japanese Journal of Medicine ·Sho Isogai, (unknown), Tsutomu Urayama	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact